Pharma Market Access Services and the Shift Toward Digital B2B Engagement

Q3. Do small biotech companies need the same market access services as large pharma?

The core service categories are similar, but scope and sequencing differ. A first-time launcher typically needs more hands-on strategy development and fewer dedicated digital/analytics resources initially, scaling up as the commercial team grows.

Q4. How is digital strategy different for payer audiences versus patient audiences?

Payer-facing digital content is typically gated, data-dense, and built around formal value dossiers and budget-impact models, while patient-facing content is simplified and subject to different regulatory review standards (e.g., DTC advertising rules).

Q5. What should be in an RFP for a market access services partner?

Ask for therapeutic area case examples, a description of how strategy and digital teams collaborate, payer research methodology, compliance review experience, and references from companies of comparable size and launch stage.